Lu-AAZTA-NI-PSMA-093
Product Specifications
UNSPSC Description
Lu-AAZTA-NI-PSMA-093 is a bivalent radiopharmaceutical agent for prostate cancer, that enhances tumor uptake and retention by combining a hypoxia-sensitive nitroimidazole (NI) moiety with a targeting moiety to PSMA[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lu-aazta-ni-psma-093.html
Smiles
O=C(O)CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNC([C@@H](NC(COC1=CC=C(C[C@H](NC(CNC(CC[C@H](NC(CCCCC2(N(CC(O3)=O)CC(O4)=O)C[N@]5(CC(O[Lu]6435OC(C7)=O)=O)CC[N@]67C2)=O)C(NCCCN8C=CN=C8[N+]([O-])=O)=O)=O)=O)C(O)=O)C=C1)=O)CC9=CC=CC=C9)=O)=O
Molecular Weight
1626.37
References & Citations
[1]Luo Y, et al., 68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer. J Med Chem. 2024 Aug 8;67(15):13491-13506.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163925/Lu-AAZTA-NI-PSMA-093-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163925/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1485116-01 0.02 mg (E-Coli)
Recombinant Caenorhabditis elegans Mediator of RNA polymerase II transcription subunit 21 (mdt-21)
Ask
View Details 
MBS1485116-02 0.1 mg (E-Coli)
Recombinant Caenorhabditis elegans Mediator of RNA polymerase II transcription subunit 21 (mdt-21)
Ask
View Details MBS1485116-03 0.02 mg (Yeast)
Recombinant Caenorhabditis elegans Mediator of RNA polymerase II transcription subunit 21 (mdt-21)
Ask
View Details MBS1485116-04 0.1 mg (Yeast)
Recombinant Caenorhabditis elegans Mediator of RNA polymerase II transcription subunit 21 (mdt-21)
Ask
View Details MBS1485116-05 0.02 mg (Baculovirus)
Recombinant Caenorhabditis elegans Mediator of RNA polymerase II transcription subunit 21 (mdt-21)
Ask
View Details